Cargando…
Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and poor prognosis. Emerging evidence suggests that epigenetic alterations play a crucial role in HCC, suggesting epigenetic inhibition as a promising therapeutic approach. Indeed, the bromodomain and extra-terminal (BET) inhibit...
Autores principales: | Baek, Mina, Chai, Jin Choul, Choi, Hae In, Yoo, Eunyoung, Binas, Bert, Lee, Young Seek, Jung, Kyoung Hwa, Chai, Young Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053788/ https://www.ncbi.nlm.nih.gov/pubmed/35486664 http://dx.doi.org/10.1371/journal.pone.0266966 |
Ejemplares similares
-
BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4
por: Choi, Hae In, et al.
Publicado: (2021) -
Analysis of differentially expressed long non-coding RNAs in LPS-induced human HMC3 microglial cells
por: Baek, Mina, et al.
Publicado: (2022) -
The BET inhibitor attenuates the inflammatory response and cell migration in human microglial HMC3 cell line
por: Baek, Mina, et al.
Publicado: (2021) -
Targeting of non-coding RNAs encoded by novel MYC enhancers inhibits the proliferation of human hepatic carcinoma cells in vitro
por: Choi, Hae In, et al.
Publicado: (2022) -
The bromodomain inhibitor JQ1 up-regulates the long non-coding RNA MALAT1 in cultured human hepatic carcinoma cells
por: Choi, Hae In, et al.
Publicado: (2022)